{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:23:14Z","timestamp":1785198194346,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.606447","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T07:29:34Z","timestamp":1607498974000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Biomodulina T (InmunyVital\u00ae) Restores T Cells and Helps Contain COVID-19"],"prefix":"10.3389","volume":"11","author":[{"given":"Roman R.","family":"Rodriguez Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Gonzalez Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Rodriguez Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene R.","family":"Rodriguez Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"B1","first-page":"72","article-title":"Biomoduladores T\u00edmicos. Revisi\u00f3n Bibliogr\u00e1fica","volume":"22","author":"Rodriguez Martin","year":"1988","journal-title":"Rev Cubana Farmacia"},{"key":"B2","first-page":"1","article-title":"Tratan hepatitis y esclerosis m\u00faltiple con sustancia extra\u00edda del timo bovino","volume":"25","author":"Rodriguez Martin","year":"1989","journal-title":"Peri\u00f3dico Granma"},{"key":"B3","first-page":"17","article-title":"Caracterizaci\u00f3n fisicoqu\u00edmica de una fracci\u00f3n de timo. I Aspectos generales","volume":"22","author":"Rodriguez Martin","year":"1993","journal-title":"Rev Cubana Med Militar"},{"key":"B4","volume-title":"Biomodulina T. Consulta M\u00e9dica. Peri\u00f3dico Granma. Junio 1","author":"Rodriguez Martin","year":"1996"},{"key":"B5","volume-title":"Biomodulina T, M\u00faltiples usos. Rev. Avances M\u00e9dicos de Cuba. A\u00f1o IV No. 9","author":"Rodriguez Martin","year":"1997"},{"key":"B6","unstructured":"Rodriguez MartinRR\n          10.2139\/ssrn.3678181History of the Discovery and Development of Biomodulina T (InmunyVital\u00ae), a Useful Immunomodulator with a Broad Range of Clinical Applications"},{"key":"B7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clim.2011.03.007","article-title":"Premature aging of the Immune System underlies immunodeficiency in Ataxia-Telangiectasia","volume":"140","author":"Exley","year":"2011","journal-title":"J Clin Immunol"},{"key":"B8","article-title":"Ensayo de Actividad Biol\u00f3gica de una fracci\u00f3n de Timo: Biomodulina T","volume":"22","author":"Rodriguez Martin","year":"1993","journal-title":"Rev Cubana Med Militar"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1159\/000230959","article-title":"Rosette-formation between guinea pig lymphoid cells and rabbit erythrocytes \u2013 a possible T-cell marker","volume":"44","author":"Wilson","year":"1973","journal-title":"Int Arch Allergy"},{"key":"B10","volume-title":"Evaluaci\u00f3n de la actividad biol\u00f3gica y aspectos inmunofarmacol\u00f3gicos de la Biomodulina T. Documentaci\u00f3n Registro Sanitario CECMED","author":"Rios Hernandez","year":"1993"},{"key":"B11","volume-title":"Estudio de la acci\u00f3n antiinflamatoria de la Biomodulina T. Tesis de grado. Lic. en Farmacia. Facultad de Farmacia y Alimentos","author":"Leon Cofi\u00f1o","year":"1994"},{"key":"B12","article-title":"Tratamiento de la Inmunodeficiencia Selectiva de IgA con Biomodulina T","volume":"23","author":"Rodriguez Martin","year":"1994","journal-title":"Rev Cubana Med Militar"},{"key":"B13","volume-title":"Enfermedad de Behcet. Tratamiento con Biomodulina T. Rev. Cub. Inv. Biomed. N\u00famero Especial","author":"Vega Sanchez","year":"1991"},{"key":"B14","volume-title":"Tratamiento de la Enfermedad de Crohn con Biomodulina T. XXII Congreso Panamericano de Enfermedades Digestivas. 14-18 octubre","author":"Jimenez Mesa","year":"1991"},{"key":"B15","volume-title":"La Biomodulina T como inmunomodulador en geriatr\u00eda. Ensayo cl\u00ednico controlado, fase II","author":"Devesa Colina","year":"1994"},{"key":"B16","volume-title":"Tratamiento de la Artritis reumatoide y Artritis reactiva con Biomodulina T. Documentaci\u00f3n Registro Sanitario","author":"Chiong Wong","year":"1994"},{"key":"B17","volume-title":"Tratamiento de Hepatitis Cr\u00f3nica Activa tipo B con Biomodulina T combinado con interfer\u00f3n alfa leucocitario. Documentaci\u00f3n Registro Sanitario Biomodulina T","author":"Vega Sanchez","year":"1993"},{"key":"B18","first-page":"3","article-title":"Efecto de la Biomodulina T 1000 sobre el Timo en ni\u00f1os con infecciones recurrentes","volume":"72","author":"Christian Lopez","year":"2000","journal-title":"Rev Cubana Pediatr\u00eda"},{"key":"B19","first-page":"68","article-title":"Biomodulina T, una opci\u00f3n terap\u00e9utica","author":"Molinet Fuertes","year":"2002","journal-title":"Rev Cubana Reumatolog\u00eda"},{"key":"B20","volume-title":"Tratamiento de la exacerbaci\u00f3n en Esclerosis M\u00faltiple con Biomodulina T. Informe final. Ensayo cl\u00ednico controlado, fase II; CENCEC","author":"Lara Rodriguez","year":"2003"},{"key":"B21","first-page":"28","article-title":"Estudio fase II de tratamiento de pacientes con Esclerosis m\u00faltiple exacerbante-remitente con Biomodulina T","volume":"8","author":"Gamez Morales","year":"2007","journal-title":"Rev Mex Neurociencias"},{"key":"B22","first-page":"1","article-title":"Uso de la Biomoduina T en el S\u00edndrome de Di George. Presentaci\u00f3n de un caso","author":"Jauma","year":"2011","journal-title":"VacciMonitor"},{"key":"B23","article-title":"S\u00edndrome de Edwards asociado a inmunodeficiencia combinada","volume":"27","author":"Marsan Suarez","year":"2011","journal-title":"Rev Cubana Hematol Inmunol Hemoter"},{"key":"B24","article-title":"Efecto terap\u00e9utico de la Biomodulina T en pacientes portadores de enfermedad pulmonar obstructiva cr\u00f3nica","volume":"10","author":"Garcia","year":"2011","journal-title":"Rev Habanera Cienc Med"},{"key":"B25","article-title":"Efecto de la Biomodulina T sobre las infecciones respiratorias altas y la polifarmacia en el anciano","volume":"13","author":"Garcia","year":"2014","journal-title":"Rev Habanera Cienc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"110633","DOI":"10.1016\/j.exger.2019.110633","article-title":"Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly","volume":"124","author":"Saavedra","year":"2019","journal-title":"Exp Gerontol"},{"key":"B27","volume-title":"Registro Sanitario de Biomodulina T. Centro Estatal para el Control de la Calidad de los Medicamentos (CECMED)","author":"Rodriguez Martin","year":"1994"},{"key":"B28","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity","volume":"183","author":"Moderbacher","year":"2020","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02247","article-title":"Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention","volume":"10","author":"Aiello","year":"2019","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Nature Cell Mol Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.abd3871","article-title":"Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans","volume":"370","author":"Mateus","year":"2020","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflamm-aging as two sides of the same coin: Friends or foes","volume":"8","author":"Fulop","year":"2018","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-012-9393-y","article-title":"Reversing T cell immunosenescence: why, who, and how","volume":"35","author":"Lang","year":"2013","journal-title":"Age (Dordr)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nri2197","article-title":"T cells calm the storm","volume":"7","author":"Tufet","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B36","volume-title":"People who are at higher risk for severe illness","year":"2020"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.37757\/MR2020.V22.N3.11","article-title":"Biomodulina T May Restore Immunity in Older Adults","volume":"22","author":"Suarez-Formigo","year":"2020","journal-title":"MEDICC Rev"},{"key":"B38","volume-title":"Use of Biomodulina T for the prevention of infections, including COVID-19 in older adults. Phase IV clinical trial. International Clinical Trials Registry Platform","year":"2020"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.606447\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T07:29:44Z","timestamp":1607498984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.606447\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2020.606447"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.606447","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"article-number":"606447"}}